Login / Signup

Avelumab for Advanced Merkel Cell Carcinoma: Global Real-World Data on Patient Response and Survival.

Rishabh LohrayKritin K VermaLeo L WangDylan HaynesDaniel J Lewis
Published in: Pragmatic and observational research (2023)
The use of avelumab as a safe and effective treatment option for advanced MCC is supported by real-world data, although additional study is required to assess long-term efficacy and safety outcomes.
Keyphrases
  • electronic health record
  • big data
  • case report
  • adipose tissue
  • machine learning
  • skeletal muscle
  • free survival
  • insulin resistance